Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZYNE
DateTimeSourceHeadlineSymbolCompany
09/02/202400:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202321:48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
12/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202313:56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202313:31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202313:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202313:00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202322:29Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202321:05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202314:00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202313:25Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202313:12Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202313:00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/09/202313:00Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202321:59Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZYNE